Navigation Links
Reportlinker Adds Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013
Date:11/20/2009

NEW YORK, Nov. 20 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013

http://www.reportlinker.com/p0164998/Oncology-Roadmap-Brand-Spending-Benchmarks-and-Market-Forecast-to-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

Comprehensive Forecasts and Detailed Budget Benchmarks new report, "Oncology Roadmap," explores the fiercely competitive oncology market in a way that no other available forecast can match.

Our experienced analysts have reviewed thousands of historical and forecasted data points to provide the most comprehensive oncology market outlook ever.

At the same time, brand budget benchmarks reveal spending in key areas throughout development and launch.

Uncover Oncology Threats and Opportunities

Equip your teams with the most comprehensive forecast of the oncology marketplace -- from today's stalwarts to tomorrow's blockbusters.

Product Breakdown

112 Anti-cancer drugs in all major classes

15 Adjuncts

Product Profile Components

-Product history

-Competitive and strategic positioning

-Market growth opportunities

-Sales history and projections

-Drug's materiality to company

Budget Brand Resources for Development and Launch

Track real brand spending from the pre-clinical period through the first year on the market

Brand Spending Benchmarks

-Advertising and promotion

-Medical affairs

-Decision support (market research)

-Market access

    Summary

    Brand Spending Benchmarks

    Average brand spending by budget category:

    - Advertising and promotion

    - Medical affairs

    - Decision support (market research)

    - Market access

    Average brand spending by development stage:

    - Pre-Clinical to phase 2

    - Phase 3a

    - Phase 3b

    - First year on the market

    Product Profiles by Class

    Brand Information

    - Brand and generic name

    - Drug class

    - Delivery mechanism

    - Line of treatment

    Sales Data

    - Historical/current sales

    - Forecasted sales

    Approved Indications

    - Current Product Development Phases

    - Competitive and Strategic Positioning

    - Market Opportunities and Brand Growth

    - Patent, Generic and Litigation Information

    Oncology Indication Analysis

    - Current sales, major drugs and important companies

    - Forecasted sales and assessment of future drugs and market players

    - Pipeline development status

    - Major market events, changes in treatments, patent expirations, etc.

    Companies' Oncology Portfolios

    - Current sales, major drugs and important companies

    - Forecasted sales and assessment of future drugs and market players

    - Pipeline development status

    Companies mentioned

    Amgen AstraZeneca Bristol-Myers Squibb Celgene Eli Lilly GlaxoSmithKline Johnson & Johnson Merck Novartis Pfizer Roche and Genentech Sanofi-Aventis Schering-Plough

    To order this report:

    Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013

    http://www.reportlinker.com/p0164998/Oncology-Roadmap-Brand-Spending-Benchmarks-and-Market-Forecast-to-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire

    More market research reports here!

    
    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626
    
    
    
    
    

    SOURCE Reportlinker


    '/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. Reportlinker Adds Pediatric Health Care Products and Services Report
9. Reportlinker Adds Botanical and Plant-Derived Drugs: Global Markets Report
10. Reportlinker Adds 2008/2009 Healthcare Research Review Report
11. Reportlinker Adds Therapeutics and Diagnostics for Womens Disorders Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, ... its strategic partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a ... effective management of complex spine deformity cases, particularly in children. , GSO’s focus ...
(Date:4/24/2017)... Lake City, UT (PRWEB) , ... April 24, 2017 , ... ... their efforts to encourage sustainability, innovate new strategies to reduce waste, and support renewable ... herbal remedy provider. They look to nature to find solutions for health issues, and ...
(Date:4/24/2017)... , ... April 24, 2017 , ... The California Dental ... in charitable dental services to 1,961 people during the April 22-23 event at the ... charge to Californians who experience barriers to care, CDA Cares educates the public and ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... seeking public support to bring their novel lifesaving device for the everyday use ... with medical-grade sensors, specially designed to read a child’s vital signs, and detect ...
(Date:4/24/2017)... CA (PRWEB) , ... April 24, 2017 , ... ... brain tumors are expected to be diagnosed globally; approximately 25,000 of them will ... are anticipating greater use of this type of healthcare model in the diagnosis ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets has announced ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ... ... technologies will rise from USD 20 Billion in 2015 to around ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2014 ... ... US$ 7,167.6 Mn in 2015, and is expected to reach ... 5.6% from 2016 to 2024. The global ...
(Date:4/19/2017)... VANCOUVER , April 19, 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) ... the Bloom Burton & Co. Healthcare Investor Conference 2017 at the ... Edward Wright , Chief Executive Officer of the Company is ... Company,s CFO, Richard Bear and the Chairman of the ... ...
Breaking Medicine Technology: